Health · Full coverage
Israeli-led study reports major breakthrough in high-risk bladder cancer treatment
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
100% right-leaning
Right 2
First reported by Arutz Sheva · Jun 14, 2026
What happened
A Shaare Zedek-led international study reports major success for a new bladder cancer treatment called NDV-01. Researchers say it produced high complete-response rates, no serious side effects, and could reshape global care if later-stage trials confirm the findings.
- 0195% of patients had complete tumor disappearance within three months.
- 0276% were cancer-free after one year, and 80% of resistant cases responded.
- 03NDV-01 uses a biodegradable gel to deliver chemotherapy inside the bladder for 14 days.
- 04No serious side effects were reported, and all patients finished treatment.
- 05The company now plans large phase 3 trials to seek global adoption.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Early Detection and Innovative Treatments Improve Bladder Cancer Outcomes in IsraelJun 29, 2026New Targeted Therapies Revolutionize Breast Cancer Treatment and Survival in IsraelJul 5, 2026Innovative Lutetium Treatment Eliminates Active Prostate Cancer in Advanced Patient at Ziv Medical Center6 days agoIsraeli Experts Highlight Advances in Personalized Treatment for Rare Mantle Cell LymphomaJul 12, 2026Weizmann Institute Discovers Viagra’s Potential to Extend Cancer Patients’ LivesJul 21, 2026Shaare Zedek Introduces Revolutionary Treatment for Complex Vascular Malformations in ChildrenJun 28, 2026
